StartUPDATES: New developments from healthcare startups
Check out new developments from Emulate, HealthMine, LuminDx, and more.
Emulate CEO shares the organ-chip maker’s vision to understand and predict drug response
Each Organ-Chip is a transparent, flexible microenvironment that contains two parallel chambers that can be configured to grow human cells from an organ of interest, such as the liver, kidney proximal tubule, intestine, lung and brain
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
StartUPDATES: New developments from healthcare startups
Check out new developments from Kiio, HealthMine, Emulate and Bind Benefits.
StartUPDATES: New developments from healthcare startups
Read about new developments from Emulate, Cellino, Heru and more.
StartUPDATES: New developments from healthcare startups
Read about news from life science companies Emulate, Astrocyte Pharmaceuticals and Bone Health Technologies.
StartUPDATES: New developments from healthcare startups
Read news from healthcare startups including Outcomes4Me, Emulate, and more.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Emulate and FDA join forces to build a better model
The hope is that the company’s liver chip will predict toxicity in humans better than current cell-based and animal models.
Organ-on-a-chip startup Emulate raises $28.75M Series B
Emulate wants its technology to "operate as a plug-and-play system in the hands of product development teams at pharmaceutical, chemical, food and consumer products companies," CEO James Coon said in a statement.